Translating discovery in zebrafish pancreatic development to human pancreatic cancer: Biomarkers, targets, pathogenesis, and therapeutics

Nelson S. Yee, Abid A. Kazi, Rosemary K. Yee

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Experimental studies in the zebrafish have greatly facilitated understanding of genetic regulation of the early developmental events in the pancreas. Various approaches using forward and reverse genetics, chemical genetics, and transgenesis in zebrafish have demonstrated generally conserved regulatory roles of mammalian genes and discovered novel genetic pathways in exocrine pancreatic development. Accumulating evidence has supported the use of zebrafish as a model of human malignant diseases, including pancreatic cancer. Studies have shown that the genetic regulators of exocrine pancreatic development in zebrafish can be translated into potential clinical biomarkers and therapeutic targets in human pancreatic adenocarcinoma. Transgenic zebrafish expressing oncogenic K-ras and zebrafish tumor xenograft model have emerged as valuable tools for dissecting the pathogenetic mechanisms of pancreatic cancer and for drug discovery and toxicology. Future analysis of the pancreas in zebrafish will continue to advance understanding of the genetic regulation and biological mechanisms during organogenesis. Results of those studies are expected to provide new insights into how aberrant developmental pathways contribute to formation and growth of pancreatic neoplasia, and hopefully generate valid biomarkers and targets as well as effective and safe therapeutics in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)132-146
Number of pages15
JournalZebrafish
Volume10
Issue number2
DOIs
StatePublished - Jun 1 2013

All Science Journal Classification (ASJC) codes

  • Animal Science and Zoology
  • Developmental Biology

Fingerprint Dive into the research topics of 'Translating discovery in zebrafish pancreatic development to human pancreatic cancer: Biomarkers, targets, pathogenesis, and therapeutics'. Together they form a unique fingerprint.

  • Cite this